Braveheart Bio, Inc. (BRVE) Insider Trading

Sector: N/A · Market Cap: $2.6B · 0 insider purchases in the last 7 days

No open market insider purchases at Braveheart Bio, Inc. in the last 7 days.

Want more?

About Braveheart Bio, Inc. Insider Trading

2 insiders at Braveheart Bio, Inc. (BRVE) have purchased stock in the past 90 days, totaling $66.3M across 3 transactions (3,683,333 shares).

The most recent purchase was by Director Viehbacher Christopher on August 7, 2026 — a $1.5M buy of 83,333 shares at $18.00, bringing his total holdings to 609,519 shares.

Insiders who purchased: Forbion Growth Opportunities Fund III Cooperatief U.A. (10%+ Owner, 2 buys totaling $64.8M); Viehbacher Christopher (Director, 1 buy totaling $1.5M).

This insider buying is notable given that BRVE had no recorded open market purchases in the nine months before that.

BRVE is in the N/A sector within the N/A industry with a market cap of $2.6B.

Track BRVE insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.